3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Glioma
3
Wilms Tumor
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Desmoplastic Small Round Cell Tumor
1
Interventions
Valproic Acid
2
Temozolomide
2
Oncolytic Virotherapy
2
Magnetic Resonance Spectroscopy
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vorasidenib
1
trametinib
1
sonidegib
1
ribociclib
1
pembrolizumab
1
palbociclib
1
mirdametinib
1
interferon gamma-1b
1
imetelstat
1
gallium Ga 68 dotatate
1
fluorodopa F 18
1
Verteporfin
1
Radiotherapy
1
ONC206
1
Interleukin-12
1
Interferon-gamma
1
Immunotherapy
1
Immunologic Techniques
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Doxorubicin
1
Dexamethasone
1
Cyproheptadine
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Neuroepithelial
×
CLR1404
×
CNS
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled